Acalabrutinib With R-CHOP in Previously Untreated Mantle Cell Lymphoma

Recruiting

Phase 2

Acalabrutinib With R-CHOP in Previously Untreated Mantle Cell Lymphoma

Sponsor:

University Health Network, Toronto

Code:

NCT04566887

Conditions

Mantle Cell Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Acalabrutinib

R-CHOP chemotherapy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by University Health Network, Toronto on 2025-02-18.